Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Stephen Sherwin


  • Director at Aduro Biotech Inc. (ADRO), 2017-06-12
  • Director at Biogen Inc. (BIIB), 2017-06-09
  • Director at Neurocrine Biosciences Inc (NBIX), 2017-06-08
  • Director at Rigel Pharmaceuticals Inc (RIGL), 2016-05-12
  • Director at Verastem Inc. (VSTM), 2015-06-16
  • Director at Vical Inc (VICL), 2015-05-26
  • Director at Biosante Pharmaceuticals Inc (BPAX), 2012-03-30
  • Officer, Director at Cell Genesys Inc (CEGE), 2009-10-15
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
VSTM $8.56 2,500 Director 2,500 2014-12-26 Filing
VICL $0.01 7,003 Director 7,003 2013-05-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BIIB $409.67 6,000 Director 4,150 2015-03-10 Filing
BIIB $279.50 3,700 Director 3,960 2014-01-02 Filing
BIIB $278.84 1,800 Director 7,660 2014-01-02 Filing
BIIB $233.54 9,392 Director 2,655 2013-06-03 Filing
BIIB $232.51 3,433 Director 12,047 2013-06-03 Filing